J&J Spin-Off Insights
J&J is gearing up for a significant IPO with its consumer unit, aiming to raise over $3.5 billion. The strategy behind the spin-off is to unlock higher valuations for its well-known brands like Tylenol and Band-Aids. A successful roadshow is crucial, as it helps gauge investor interest and set the pricing for the offering, ideally leading to an oversubscribed situation that benefits all parties involved.In this clip
From this podcast
Prof G Markets
Prof G Markets: Fox’s Stock After Tucker Carlson, J&J’s IPO Roadshow, and Google and Meta’s Earnings
Related Questions